1. Home
  2. SEED vs BFRG Comparison

SEED vs BFRG Comparison

Compare SEED & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Origin Agritech Limited

SEED

Origin Agritech Limited

SELL

Current Price

$0.69

Market Cap

8.5M

ML Signal

SELL

Logo Bullfrog AI Holdings Inc.

BFRG

Bullfrog AI Holdings Inc.

SELL

Current Price

$0.51

Market Cap

8.6M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
SEED
BFRG
Founded
1997
2017
Country
China
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Retail: Computer Software & Peripheral Equipment
Sector
Consumer Staples
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.5M
8.6M
IPO Year
2005
2022

Fundamental Metrics

Financial Performance
Metric
SEED
BFRG
Price
$0.69
$0.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
15.3K
★ 145.7K
Earning Date
05-21-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 25.88
EPS
★ N/A
N/A
Revenue
N/A
★ $116,670.00
Revenue This Year
N/A
$568.55
Revenue Next Year
N/A
$573.08
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 79.49
52 Week Low
$0.65
$0.43
52 Week High
$1.73
$1.96

Technical Indicators

Market Signals
Indicator
SEED
BFRG
Relative Strength Index (RSI) 41.77 44.54
Support Level $0.67 $0.44
Resistance Level $1.07 $0.69
Average True Range (ATR) 0.05 0.04
MACD -0.00 0.00
Stochastic Oscillator 19.11 26.96

Price Performance

Historical Comparison
SEED
BFRG

About SEED Origin Agritech Limited

Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.

About BFRG Bullfrog AI Holdings Inc.

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. The Company is focused specifically on advance artificial intelligence and machine learning (AI/ML)- driven analysis of complex datasets in medicine and healthcare. The Company's objective is to use its AI/ML platform to provide a precision-medicine approach to drug-asset enablement through external partnerships and selective internal development.

Share on Social Networks: